Pharmaceutical company and leading insulin manufacturer Novo Nordisk is offering a free 90-day supply of insulin to people with diabetes who have lost their health coverage due to a change in job status because of the continued coronavirus outbreak.
The free 90-day insulin supply is available through the company’s Diabetes Patient Assistance Program (PAP), which it has modified to help Americans facing job loss or a loss of health care benefits due to the pandemic. Under the new ‘COVID-19 job-loss exceptions’ section of the PAP application page, Novo Nordisk has said that applicants don’t need to provide proof of income, but they do need to submit paperwork demonstrating a loss of health benefits from job termination. The documentation required is as follows:
- Complete Patient Assistance Program (PAP) application
- Documentation showing loss of healthcare benefits (job termination notice, job status change, proof that COBRA benefits are being offered)
If approved, you will receive a free 90-day supply of insulin from Novo Nordisk. You can apply here to find out if you are eligible.
"The pandemic is taking a serious toll on the nation's health and economy. Millions of people are losing jobs and health coverage, and that's especially tragic if you have a chronic disease like diabetes,” said Doug Langa, Executive Vice President, North America Operations and President of Novo Nordisk Inc, in a statement released to the press. “We already have a lot of programs to help people afford insulin but the impact of COVID-19 goes beyond that.”
"Removing barriers is so important right now. The US healthcare system has been long overdue for intervention and this crisis brings things so clearly into focus,” added Kelly Close, President and Founder, Close Concerns, and Founder and Chair of the Board of The diaTribe Foundation. “Navigating our healthcare system is hard enough as it is for people with diabetes, in addition to living in this pandemic and managing a serious chronic disease.”
Diabetes care and health insurance coverage
According to figures included in the CDC’s 2020 National Diabetes Statistics Report, the condition affects roughly 34.2million people in the United States. The cost of insulin is notoriously high too, and to curb rising prices, lawmakers across the US are looking at capping costs. For example, New Mexico, Illinois and Colorado have passed legislation to cap the cost of insulin co-pays.
Insulin is a prescription drug used to control diabetes. Injectable insulin not used with an insulin infusion pump is covered by the best Medicare Part D plans. An insulin pump worn outside the body, including the insulin used with the pump, might be covered for some people under Medicare Part B, as pumps are considered to be ‘durable medical equipment’ (DME). Medicare Part B also covers blood sugar monitors, which we have reviewed in our guide to the best glucose meters.
The Centers for Medicare and Medicaid Services has produced a comprehensive guide to Medicare coverage of diabetes for people who would appreciate further insight. If you don’t currently have health coverage, we have also reviewed the best health insurance companies spanning a range of health coverage needs.